Literature DB >> 34839399

Cardiovascular disease risk reduction with wolfberry consumption: a systematic review and meta-analysis of randomized controlled trials.

Darel Wee Kiat Toh1, Jasmine Hui Min Low1, Jung Eun Kim2.   

Abstract

PURPOSE: Wolfberry is rich in bioactive compounds which may lower cardiovascular disease risk. This meta-analysis aimed to systematically evaluate the effects of wolfberry-based randomized controlled trials (RCTs) on overall cardiovascular health.
METHODS: Four online databases (PubMed, CINAHL Plus, Medline and Cochrane Library) were searched to shortlist relevant RCTs. Outcomes of interests included blood lipids and lipoproteins, blood pressure, biomarkers of oxidative stress, inflammation and other cardiovascular health-related indicators. Random-effects models were used to provide a weighted mean difference (WMD) and/or Hedges' g for quantitative synthesis. This was coupled with subcategory analyses which stratified RCTs according to the form in which wolfberry was administered (whole wolfberry versus wolfberry extract).
RESULTS: From the 785 articles identified, 10 were selected for meta-analysis. Compared to the control, groups which consumed wolfberry showed a reduction in blood triglycerides [WMDpooled (95% confidence interval): - 0.14 (- 0.19, - 0.09) mmol/L] and increased blood high-density lipoprotein cholesterol [WMDpooled: 0.06 (0.02, 0.09) mmol/L]. Notably, effects for both triglycerides [WMDwhole: - 0.14 (- 0.19, - 0.09) mmol/L; WMDextract: - 0.07 (- 0.30, 0.16) mmol/L] and high-density lipoprotein cholesterol [WMDwhole: 0.06 (0.02, 0.09) mmol/L; WMDextract: 0.05 (- 0.02, 0.13) mmol/L] were more prominent after whole wolfberry interventions. Additionally, blood malondialdehyde equivalents were also significantly decreased in wolfberry consuming groups [Hedges' gpooled: - 1.45 (- 2.75, - 0.16)]. No changes were observed for the other lipids and lipoproteins as well as blood pressure.
CONCLUSIONS: Wolfberry consumption is effective in improving blood lipids and lipoproteins profile and lowering oxidative stress. This supports the incorporation of wolfberry, particularly as whole fruits, into dietary patterns targeted at improving cardiovascular health.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Cardiovascular disease; Lipid; Lipoprotein; Lycium; Oxidative stress; Systematic review and meta-analysis

Mesh:

Substances:

Year:  2021        PMID: 34839399     DOI: 10.1007/s00394-021-02750-6

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  35 in total

1.  Effect of Lycium barbarum polysaccharide on the improvement of antioxidant ability and DNA damage in NIDDM rats.

Authors:  Hao Wu; Hongwei Guo; Rui Zhao
Journal:  Yakugaku Zasshi       Date:  2006-05       Impact factor: 0.302

Review 2.  The effects of Lycium barbarum L. (L. barbarum) on cardiometabolic risk factors: a meta-analysis of randomized controlled trials.

Authors:  Xiao-Fei Guo; Zi-Hao Li; Huizhen Cai; Duo Li
Journal:  Food Funct       Date:  2017-05-24       Impact factor: 5.396

3.  Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum.

Authors:  Qiong Luo; Yizhong Cai; Jun Yan; Mei Sun; Harold Corke
Journal:  Life Sci       Date:  2004-11-26       Impact factor: 5.037

4.  A milk-based wolfberry preparation prevents prenatal stress-induced cognitive impairment of offspring rats, and inhibits oxidative damage and mitochondrial dysfunction in vitro.

Authors:  Zhihui Feng; Haiqun Jia; Xuesen Li; Zhuanli Bai; Zhongbo Liu; Lijuan Sun; Zhongliang Zhu; Peter Bucheli; Olivier Ballèvre; Junkuan Wang; Jiankang Liu
Journal:  Neurochem Res       Date:  2010-02-05       Impact factor: 3.996

Review 5.  Goji (Lycium barbarum and L. chinense): Phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity.

Authors:  Olivier Potterat
Journal:  Planta Med       Date:  2009-10-20       Impact factor: 3.352

6.  Protective effect of Lycium barbarum on doxorubicin-induced cardiotoxicity.

Authors:  Yan-Fei Xin; Guo-Liang Zhou; Zu-Yue Deng; Yun-Xiang Chen; Yue-Guo Wu; Pan-Sheng Xu; Yao-Xian Xuan
Journal:  Phytother Res       Date:  2007-11       Impact factor: 5.878

7.  Ultrastructural deposition forms and bioaccessibility of carotenoids and carotenoid esters from goji berries (Lycium barbarum L.).

Authors:  Judith Hempel; Christopher N Schädle; Jasmin Sprenger; Annerose Heller; Reinhold Carle; Ralf M Schweiggert
Journal:  Food Chem       Date:  2016-09-10       Impact factor: 7.514

Review 8.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

9.  Thoracic aorta vasoreactivity in rats under exhaustive exercise: effects of Lycium barbarum polysaccharides supplementation.

Authors:  Zhifang Zhao; Yan Luo; Guanghua Li; Lingqin Zhu; Yin Wang; Xuehong Zhang
Journal:  J Int Soc Sports Nutr       Date:  2013-10-24       Impact factor: 5.150

10.  Microstructural and histochemical characteristics of Lycium barbarum L. fruits used in folk herbal medicine and as functional food.

Authors:  Agata Konarska
Journal:  Protoplasma       Date:  2018-06-15       Impact factor: 3.356

View more
  1 in total

Review 1.  Health Benefits and Applications of Goji Berries in Functional Food Products Development: A Review.

Authors:  Bojana B Vidović; Danijel D Milinčić; Mirjana D Marčetić; Jelena D Djuriš; Tijana D Ilić; Aleksandar Ž Kostić; Mirjana B Pešić
Journal:  Antioxidants (Basel)       Date:  2022-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.